These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 20046156)
1. Visfatin genotype may modify the insulin resistance and lipid profile in type 2 diabetes patients. Mirzaei K; Hossein-Nezhad A; Javad Hosseinzadeh-Attar M; Jafari N; Najmafshar A; Mohammadzadeh N; Larijani B Minerva Endocrinol; 2009 Dec; 34(4):273-9. PubMed ID: 20046156 [TBL] [Abstract][Full Text] [Related]
2. The relationship between circulating visfatin/nicotinamide phosphoribosyltransferase, obesity, inflammation and lipids profile in elderly population, determined by structural equation modeling. Owczarek AJ; Olszanecka-Glinianowicz M; Kocełak P; Bożentowicz-Wikarek M; Brzozowska A; Mossakowska M; Puzianowska-Kuźnicka M; Grodzicki T; Więcek A; Chudek J Scand J Clin Lab Invest; 2016 Dec; 76(8):632-640. PubMed ID: 27712122 [TBL] [Abstract][Full Text] [Related]
3. The visfatin gene is associated with glucose and lipid metabolism in a Chinese population. Jian WX; Luo TH; Gu YY; Zhang HL; Zheng S; Dai M; Han JF; Zhao Y; Li G; Luo M Diabet Med; 2006 Sep; 23(9):967-73. PubMed ID: 16922702 [TBL] [Abstract][Full Text] [Related]
4. Visfatin is associated with lipid metabolic abnormalities in Lyon hypertensive rats. Wang P; Bai C; Xu QY; Xu TY; Su DF; Sassard J; Miao CY Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):894-9. PubMed ID: 20456420 [TBL] [Abstract][Full Text] [Related]
5. [Role of visfatin in the pathogenesis of gestational diabetes mellitus and its relationship with insulin resistance]. Huo Y; Liu S; Feng J; Li H; Fan Y; Jin Y; Li L Zhonghua Fu Chan Ke Za Zhi; 2014 Aug; 49(8):584-7. PubMed ID: 25354858 [TBL] [Abstract][Full Text] [Related]
6. Visfatin and insulin levels and cigarette smoking are independent risk factors for hidradenitis suppurativa: a case-control study. Akdogan N; Alli N; Uysal PI; Topcuoglu C; Candar T; Turhan T Arch Dermatol Res; 2018 Dec; 310(10):785-793. PubMed ID: 30293125 [TBL] [Abstract][Full Text] [Related]
7. Serum CRP levels are equally elevated in newly diagnosed type 2 diabetes and impaired glucose tolerance and related to adiponectin levels and insulin sensitivity. Yuan G; Zhou L; Tang J; Yang Y; Gu W; Li F; Hong J; Gu Y; Li X; Ning G; Chen M Diabetes Res Clin Pract; 2006 Jun; 72(3):244-50. PubMed ID: 16377022 [TBL] [Abstract][Full Text] [Related]
8. Obesity and Cardiovascular Risk: Variations in Visfatin Gene Can Modify the Obesity Associated Cardiovascular Risk. Results from the Segovia Population Based-Study. Spain. Martínez Larrad MT; Corbatón Anchuelo A; Fernández Pérez C; Pérez Barba M; Lazcano Redondo Y; Serrano Ríos M; PLoS One; 2016; 11(5):e0153976. PubMed ID: 27166797 [TBL] [Abstract][Full Text] [Related]
9. Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects. Li L; Yang G; Li Q; Tang Y; Yang M; Yang H; Li K Exp Clin Endocrinol Diabetes; 2006 Nov; 114(10):544-8. PubMed ID: 17177135 [TBL] [Abstract][Full Text] [Related]
10. [Association between both resistin, visfatin and insulin resistance as well as β cell function in the first-degree relatives of type 2 diabetes mellitus]. Zhang XJ; Wang Z; Li HH; Yu L; Gao S Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Dec; 31(12):1393-6. PubMed ID: 21223671 [TBL] [Abstract][Full Text] [Related]
11. Correlation between polymorphisms in the visfatin gene and its expression in the serum and coronary artery calcification. Jin LW; Zheng SB; Zhou ZH; Pan SF; Zheng Y Genet Mol Res; 2016 Jul; 15(2):. PubMed ID: 27421003 [TBL] [Abstract][Full Text] [Related]
12. Serum visfatin and its relation to insulin resistance and inflammation in type 2 diabetic patients with and without macroangiopathy. Alghasham AA; Barakat YA Saudi Med J; 2008 Feb; 29(2):185-92. PubMed ID: 18246224 [TBL] [Abstract][Full Text] [Related]
13. Compare the effects of different visfatin concentration on cardiovascular risk factors, adiponectin and insulin resistance in patients with T2DM. Mohammadi S; Hosseinzadeh-Attar MJ; Hosseinnezhad A; Hosseini SH; Eshraghian MR; Nezhad MK; Rahmani M; Karimi M Diabetes Metab Syndr; 2011; 5(2):71-5. PubMed ID: 22813406 [TBL] [Abstract][Full Text] [Related]
14. Elevated visfatin levels in obese children are related to proinflammatory factors. Li RZ; Ma Xn; Hu XF; Kang SX; Chen SK; Cianflone K; Lu HL J Pediatr Endocrinol Metab; 2013; 26(1-2):111-8. PubMed ID: 23327785 [TBL] [Abstract][Full Text] [Related]
15. Serum visfatin levels in women with polycystic ovary syndrome. Güdücü N; İşçi H; Görmüş U; Yiğiter AB; Dünder I Gynecol Endocrinol; 2012 Aug; 28(8):619-23. PubMed ID: 22313145 [TBL] [Abstract][Full Text] [Related]
16. [Visfatin in obese patients, relation with cardiovascular risk factors, a cross sectional study]. de Luis DA; Ballesteros M; Ruiz E; Muñoz C; Penacho A; Iglesias P; Guzmán AL; Abreu C; Maldonado A; Delgado M; Martín LS; Puigdevall V; Romero E; Sagrado MG; Izaola O; Conde R; Med Clin (Barc); 2011 Jul; 137(5):199-203. PubMed ID: 21296365 [TBL] [Abstract][Full Text] [Related]
17. Dietary fat intake associated with bone mineral density among visfatin genotype in obese people. Khorrami-Nezhad L; Mirzaei K; Maghbooli Z; Keshavarz SA Br J Nutr; 2018 Jan; 119(1):3-11. PubMed ID: 29355093 [TBL] [Abstract][Full Text] [Related]
18. The effect of visfatin genotype on insulin pump therapy on quality of life in patients with type I diabetes. Jianjun L; Xiaona L; Hong L Cell Mol Biol (Noisy-le-grand); 2022 Jan; 67(4):195-202. PubMed ID: 35809287 [TBL] [Abstract][Full Text] [Related]
19. Relation of visfatin to cardiovascular risk factors and adipocytokines in patients with impaired fasting glucose. de Luis DA; Sagrado MG; Conde R; Aller R; Izaola O Nutrition; 2013; 29(11-12):1300-3. PubMed ID: 19131213 [TBL] [Abstract][Full Text] [Related]
20. Visfatin Serum Levels in Obese Type 2 Diabetic Patients: Relation to Proinflammatory Cytokines and Insulin Resistance. Hetta HF; Ez-Eldeen ME; Mohamed GA; Gaber MA; ElBadre HM; Ahmed EA; Abdellatief RB; Abd-ElBaky RM; Elkady A; Nafee AM; Zahran AM; Ahmad M Egypt J Immunol; 2018 Jun; 25(2):141-151. PubMed ID: 30600957 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]